Acceptance of fenoterol powder for inhalation in children with bronchial asthma.
Eighteen children with perennial bronchial asthma, aged 10.3 years, were studied with respect to their attitude to inhalation of fenoterol, a beta 2-agonist, in powder form. Treatment with fenoterol powder was performed for 3 months and questionnaires were answered after 1 and 3 months. Almost all children showed a positive attitude towards handling capsules and inhaler. Inhaling powder was well accepted and the effect of the powder on asthma symptoms was regarded as good. Although the positive attitude to continue with powder inhalations declined somewhat at the end of the observation period, this type of therapy seemed to be well accepted by children.
D000281:Administration, Intranasal; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D004983:Ethanolamines / Q000008:administration & dosage*; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010349:Patient Compliance; D011208:Powders
D000336:Aerosols; D004983:Ethanolamines; D011208:Powders; D005280:Fenoterol